Rhinogen BPE

Manufacturer: Intervet/Merck Animal Health

Bordetella Bronchiseptica-erysipelothrix Rhusiopathiae-pasteurella Multocida Bacterin-toxoid

For use in healthy swine as an aid in the prevention of atrophic rhinitis and pneumonia caused by Bordetella bronchiseptica and Pasteurella multocida nontoxigenic type A and toxigenic types A and D, and erysipelas caused by Erysipelothrix rhusiopathiae. A chemically inactivated, adjuvanted culture of B. bronchiseptica, E. rhusiopathiae and P. multocida nontoxigenic type A and toxigenic type D.

Dosage And Directions

Shake well, inject intramuscularly or subcutaneously.

Sows And Gilts

One 2 mL dose at 5 weeks and 2 weeks prefarrowing; one 2 mL dose at 1-2 weeks before subsequent farrowings.

Baby Pigs

One 1 mL dose at 5-7 days of age; one 1 mL dose at 23-28 days of age.

Feeder Pig Vaccination

One 1 mL dose at weaning (3 weeks of age); one 1 mL dose 3 weeks later.

Boars

One 2 mL dose annually.

Rhinogen BPE Caution

Store in the dark at not over 45°F (7°C). Do not freeze. Use entire contents when first opened; do not save partial contents. Use only in healthy swine. Do not vaccinate within 21 days of slaughter. If allergic reaction occurs, treat with epinephrine. Transient local swelling may occur at site of injection. Not to be used as a diluent for viral products. Contains gentamicin and thimerosal as preservatives.

For Veterinary Use Only

INTERVET INC., Millsboro, DE 19966

U.S. Veterinary License No. 165A

		Code
100 piglet or 50 sow doses	100 mL	026132	7125002

Nac No.

10473711